Import and export of metabolites through mitochondrial membranes are vital processes that are highly controlled and regulated at the level of the inner membrane. Proteins of the mitochondrial carrier family (MCF) are embedded in this membrane, and each member of the family achieves the selective transport of a specific metabolite. Among these, the ADP/ATP carrier transports ADP into the mitochondrial matrix and exports ATP toward the cytosol after its synthesis. Because of its natural abundance, the ADP/ATP carrier is the best characterized within MCF, and a high-resolution structure of one conformation is known. The overall structure is basket shaped and formed by six transmembrane helices that are not only tilted with respect to the membrane, but three of them are also kinked at the level of prolines. The functional mechanisms, nucleotide recognition, and conformational changes for the transport, suggested from the structure, are discussed along with the large body of biochemical and functional results. 
INTRODUCTION
Cell compartmentalization into organelles limited by membranes, allowing segregation Mitochondrial carrier family (MCF): proteins of the inner mitochondrial membrane, which shuttle substrates in and out
IMS:
intermembrane space TM: transmembrane of various cell functions in different locations of the cellular space, implies that a complex communications network needs to be set up and regulated. In most cases, molecules involved in intracellular trafficking have to pass through membranes, and specific transport proteins generally catalyze these journeys. This is particularly true with charged species because the lipid bilayer of membranes is an effective barrier to anions and cations.
Solute transports through membranes are essential steps in many metabolic pathways. Mitochondria are particularly rich in solute carriers, and most of these constitute the socalled mitochondrial carrier family (MCF) (1) , also referred to as SLC25. About 20 distinct transport functions are involved in the fluxes of the various metabolites through the inner mitochondrial membrane, which is the only mitochondrial permeability barrier, the outer membrane being freely permeable to molecules up to approximately 5000 Da. All of the characterized carriers are not always present in all tissues, according to the occurrence of tissue-specific metabolic pathways.
Among MCF members, the ADP/ATP carrier is the most abundant and, along with the phosphate carrier, appears indispensable to mitochondria. It can be considered the paradigm of mitochondrial metabolite carriers because several major findings of carrier structures and mechanisms have been first produced through studies of the ADP/ATP carrier. Albeit the function of all the members of the MCF have not yet been identified, they share main structural and functional characteristics that are summarized as follows: (a) all mitochondrial carriers are encoded by nuclear genes, (b) the primary structure of most carriers displays three repeated homologous regions of about 100 amino acids each, (c) the N and C termini face the intermembrane space (IMS) and six transmembrane (TM) segments can be delineated, (d) a common sequence, the MCF motif, can be found in each repeated region with slight deviations on one or two signature sequences for some carriers, and (e) comparison of primary structures indicates that mitochondrial carriers have no orthologues in prokaryotes, their emergence seems to be the evolutionary consequence of the capture of an ancient aerobic procaryotic cell by the primitive eucaryotic cell.
Although high-resolution structures are important tools to tackle functional mechanisms, structures of membrane proteins are still far behind expectations owing to difficulties in getting sufficient amounts of pure and well-folded proteins and in crystallizing such amphipatic molecules (2) . Furthermore, transporters often undergo large conformational changes, and therefore solutions of solubilized proteins are highly inhomogeneous in terms of conformations. Obtaining wellordered three-dimensional crystals is more likely to occur when a single conformation has been locked either by a mutation as for lactose permease (3) or by the presence of an inhibitor as discussed herein for the ADP/ATP carrier (4) . Two-dimensional crystallization is an alternative approach to structure determination by X-ray crystallography, which might favor protein stability because the protein is embedded in a flat lipidic bilayer. Even though the resolution obtained by electron microscopy is usually lower, it is an interesting complementary approach that might help elucidate larger conformational changes. The ADP/ATP carrier is the only MCF carrier for which the three-dimensional structure of one conformation is known. The first projected structure of a yeast isoform complexed to atractyloside (ATR) was obtained by electron microscopy (5, 6) . The high-resolution structure of the bovine carrier was solved to 2.2Å in the presence of carboxyatractyloside (CATR) (4) , and a second crystal form of the same protein gave additional information on cardiolipins (CDLs) (7) . This review discusses mainly structure-function relationships, combining structural with biochemical and functional data.
BRIEF HISTORY
The concept of a mitochondrial carrier for adenine nucleotides arose in the 1960s as a result of the convergence of two independent series of observations described by researchers working at deciphering the mitochondrial phosphorylation process.
In 1955, a pioneering study by Siekevitz & Potter (8) established that two distinct pools of adenine nucleotides were operating coopera-
HUMAN DISEASE AND THE ADP/ATP CARRIER
Disorders in the mitochondrial energy-generating system are reflected by a variety of clinical symptoms ranging from myopathy, with lactic acidosis, to severe multisystem disease, involving the central nervous or cardiac system. In most cases, the origin of the disease is evidenced by a defect in one of the components of the respiratory chain and is due to mutations in either the mitochondrial or the nuclear genome. For some patients, however, impairment of the mitochondrial function cannot be ascribed to such defects. Almost 25% of the patients suffering from such a dysfunction do not show clear impairments of the respiratory chain. In some cases, metabolite carriers, including the ADP/ATP carrier, might be the cause of the pathology. Mitochondrial myopathies implicating the ADP/ATP carrier have been described in human and in mouse, and these myopathies may be involved in several cases of autosomal dominant progressive ophthalmoplegia.
High-resolution structure: three-dimensional protein structures with atomic details usually obtained by X-ray crystallography
ATR: atractyloside

CATR: carboxyatractyloside
Cardiolipin (CDL):
an anionic phospholipid in which a glycerol moiety links two phosphatidyl groups tively in the oxidative phosphorylation pathway, one located in the mitochondrial matrix and the other in the cytosol. Soon after, Pressman (9) reported that although the intramitochondrial concentrations of nucleotides were largely kept unaffected by the extramitochondrial concentration, "an extremely dynamic interchange of nucleotides" took place between the two pools. To rationalize these findings, the hypothesis put forward at that time was "the existence of a fixed quantity" of an intramitochondrial component with sufficient affinity for adenine nucleotides. Curiously enough, there was no mention of a putative adenine nucleotide transporter although Bartley & Davies (10) had already advanced the possibility of transporters for mitochondrial respiratory substrates.
The second series of findings came from studies aimed at elucidating the poisonous effect of a natural drug, ATR, extracted from the thistle Atractylis gummifera, which is widespread in Mediterranean countries. This plant had been already described two thousand years ago by Dioscorides (∼40-90 AD) as a medicinal herb in his famous herbal
BA: bongkrekic acid
De Materia Medica. ATR is a diterpene heteroglucoside of which two sulfate residues make it strongly anionic at physiological pH and thereby nonpermeable through the mitochondrial membrane.
In 1962, Bruni et al. (11) and Vignais et al. (12) reported that ATR inhibited specifically the oxidative phosphorylation of extramitochondrial ADP. In the following years, these results were confirmed by several others groups (13) (14) (15) , and it was clearly demonstrated that ATR did not inhibit the phosphorylation of intramitochondrial ADP. Then the obvious conclusion suddenly appeared that ATR was inhibiting the entry of ADP into mitochondria, and consequently, the existence of a transporter for ADP was postulated. Subsequently, detailed analyses of the kinetic properties of the adenine nucleotide transport (16, 17) allowed the characterization of an exchange-diffusion process between the intramitochondrial ADP and ATP with either ADP or ATP added to mitochondria; no other nucleotide could be a substrate for the carrier. The finding, not fully appreciated at that time, by Bruni et al. (11) that ATR inhibits the binding of adenine nucleotides to rat liver mitochondria, was instrumental later in the identification of the substrate carrier sites when radioactively labeled inhibitors became available.
In 1970, following preliminary studies by Welling et al. (18) , Henderson & Lardy (19) introduced bongkrekic acid (BA), a complex fatty acid derivative, as an ADP/ATP carrier inhibitor. It is produced and secreted by the bacteria Pseudomonas cocovenenans and binds to the matrix side of the carrier after diffusion through the membrane. From that time to 1982, when the protein sequence of the ADP/ATP carrier was determined, a large body of results dealing with the properties of the carrier accumulated. These studies greatly benefited from the availability of the two families of inhibitors of exquisite specificity and affinity. The asymmetrical binding of the two classes of inhibitors allowed the characterization of two stable conformational states of the carrier, which possibly represent two extreme configurations close to that exhibited during the transport cycle by the carrier.
The other major findings are briefly summarized as follows: (a) When mitochondria are actively respiring in the presence of phosphate and ADP, the latter is exchanged against intramitochondrial ATP with a 1-to 1-stoichiometry; (b) the only physiological substrates are ADP and ATP, surprisingly, in their free forms, i.e., Mg-ADP and Mg-ATP are not recognized by the carrier; (c) the ADP/ATP exchange is electrogenic, which means one negative charge is extruded from the matrix to the cytosol for each cycle, and this process is driven by the membrane potential; (d) the kinetic parameters of the carrier are consistent with the mitochondrial ATP production and the cell nucleotide concentrations under physiological conditions; and (e) the carrier could be purified in detergent solutions, and transport activity could be reconstituted after reincorporation into liposomes.
To investigate the structure and characterize the conformational states of the ADP/ATP carrier, photoactivable derivatives of ADP/ATP or of the inhibitors were designed and tested either with the bovine carrier or with the yeast carrier ( Table 1) . Several authors found evidence that both conformational states expose quite different amino acid regions, and the differences were further highlighted with the use of specific proteases and antibodies directed against the ADP/ATP carrier. Site-directed mutagenesis was applied mainly to the yeast ADP/ATP carrier isoform 2 to identify residues potentially crucial for the binding or transport mechanism. Some positive and negative residues were thus proposed to be essential ( Table 1) . This approach, though promising, was limited to some residues in the absence of structural data. However, the search for second-site revertants starting from welldefined inactive mutants ( Table 1) led to the proposed network of potentially interacting amino acids that can be now reexamined in the light of the three-dimensional bovine carrier structure. So far, only one charge pair suspected in the yeast carrier is confirmed in the bovine structure (D134-R234 of the bovine protein). However, the other pairs are in the vicinity of the ones evidenced in the bovine structure. All in all, this does not invalidate the general use of mutants because bovine and yeast amino acid sequences, although pretty similar, are different enough to suppose the involvement of different networks of structurally related amino acids.
It is interesting to note that in addition to the adenine nucleotide carrier, four other nucleotide transporters belonging to MCF have been identified: the mitochondrial carriers for GDP/GTP (20) , dNDP/dNTP (21) , and Mg-ATP/Pi (22) and, surprisingly, also the peroxisomal AMP/ADP/ATP carrier (23) . All of these carriers are insensitive to ATR, and in contrast to the ADP/ATP carrier, the charges of their nucleotide substrates are partially or totally neutralized by Mg 2+ or by H + , with a possible exception of the dNDP/dNTP transporter. In addition, they also usually exhibit a lower specificity regarding either the base moiety or the polyphosphate chain length, and finally, their rate capacity is approximately 15-to 30-fold lower.
STRUCTURE ANALYSIS
The ADP/ATP carrier was crystallized in two different forms (7, 24) . In both crystal forms, proteins surrounded by lipids are packed within layers as if they are sitting in a membrane. Three-dimensional crystals consist of stacks of these layers. The model of the protein structure was refined from the best diffracting crystal form (4) and deposited in the Protein Data Bank under accession code 1okc. From the N to the C termini, both located in the IMS, the overall architecture consists of six TM helices labeled H1 to H6, connected by three loops M1 to M3 on the matrix side and two loops C1 and C2 on the IMS (Figures 1 and 2a) . Matrix loops are partially structured and contain short amphipatic helices (labeled h1-2, h3-4, and h5-6) spanning over 12 residues (Figure 1c) . Odd-numbered TM helices are sharply kinked (20 • to 35
• ), and all the six TM helices are also tilted with respect to the membrane. As a result, the backbone of the ADP/ATP carrier is shaped similar to a basket, closed toward the matrix and opened widely toward the IMS. The backbone also exhibits a pseudo-threefold symmetry consistent with the triplicated sequence of the gene. Most of the residues are well defined in the model, except a few residues at the N and C termini, which are probably disordered in the crystal. Residues located in IMS loops exhibit larger Debye-Waller factors than others, which is also indicative of partial disorder, preventing some of the side chains to be modeled.
The Cavity
The cavity, formed by the TM helices, is mainly hydrophilic and enters very deeply into the protein. It is shaped conically with an entrance diameter of about 20Å, followed by a narrow funnel over 20Å long with a diameter of 8Å, and it is closed at 10Å from the matrix side (Figure 3) . Several patches of basic residues are observed. They are formed by residues K198/R104, R187/K91/K95, K22/R79/R279, and K32/R137/R234/R235 (labeled 1 to 4 in Figure 4 ) and located from the entrance to the bottom of the cavity. Facing the second patch at roughly 10Å distance from it, Y194 is the first of three tyrosines, Y194/Y190/Y186; this arrangement forms a ladder along H4, entering the cavity. The ladder ends at the level of the third basic patch, where the conic cavity is constricted to 8Å by four residues Y186/K22/R79/R279. The presence of many charged or polar residues within the cavity is balanced by well-ordered water molecules, forming extensive hydrogen-bond networks involving both water molecules and amino acid side chains. One of the largest networks connects all TM helices except H4 and involves the side chains of K22, E29, K32, Q36, N76, R79, D134, R137, T232, rr The arginine to histidine change corresponds to the op1 mutation first described by Slonimski and collaborators (107) and later identified by Kolarov and collaborators (108) .
Figure 1
Overall structure of the bovine ADP/ATP carrier. The ribbon diagram, colored blue to red from the N terminus (N) to the C terminus (C), depicts transmembrane helices (H1-H6), loops facing the IMS (C1 and C2), and loops facing the matrix (M1-M3). Matrix loops are partially structured in short helices (h1-2, h3-4, and h5-6). Three cardiolipins (CDLs), CDL800, CDL801, and CDL802, are bound to the structure and represented as ball and sticks in gray. The inhibitor, CATR, complexed with the protein is depicted in yellow. Panels a, b, c are viewed from the IMS, the side, and the matrix, respectively. The color code for the ribbon diagram is the same as for Figures 2, 3 , 6, 7, and 11.
R234, R235, N276, R279 and about 20 water molecules ( Figure 5) . Almost all the residues described in this paragraph are conserved among ADP/ATP carriers (see the supplementary material). Follow the Supplemental Material link from the Annual Reviews home page at http://www.annualreviews.org.
CATR Binding
The inhibitor CATR, cocrystallized with the carrier, is located within the cavity with its diterpene moiety oriented toward the bottom and its sulfate groups toward the IMS (see figure 5 in Reference 4). The inhibitor binds to the carrier through numerous interactions that involve all the chemical groups except the primary alcohol located on the sugar ring. This structural observation is consistent with the inhibitory properties of CATR, which are reduced once the molecule is truncated or modified, except for the primary alcohol that can be modified without changing the inhibition capacity (25) . The two carboxylates and the hydroxyl group on the diterpene moiety, as well as both sulfates on the glucose ring, are linked to the carrier through electrostatic interactions or hydrogen bonds, some of which also involve water molecules. The isovaleric chain and the diterpene ring interact via van der Waals contacts.
The MCF Motif
MCF members are characterized by triplication of the following motif: PxD/ExxK/RxK/ R-(20 to 30 residues)-D/EGxxxxaK/RG, where the letter a represents an aromatic residue (Figure 2b) . Several authors refined this motif by restricting some residues labeled as x (26) . The PxD/ExxK/R sequence can be directly related to the basket shape of the carrier. Indeed, the prolines located in the second half of odd-numbered helices, close to the matrix, induce sharp kinks responsible for the closed form toward the matrix. 
150 160 170 known that, in the absence of other specific interactions, proline residues can adopt a broad range of stable conformations (27) . Therefore, when present in helices, surrounding interactions might induce a given kink angle. This is probably partly achieved by the acidic and basic residues that follow the prolines and form salt bridges that strengthen the closed conformation of the helix bundle (Figure 6) . If the surrounding interactions are modified, the kink angles may be changed. Therefore, the prolines were proposed to act as hinges that could allow the opening toward the matrix, which could be triggered by the disruption of the salt bridges (28) . However, it was also proposed that, during evolution, prolines could have mutated into serines and that subsequent packing defects were compensated by other mutations locking the kink in the structure (29) . This could explain why the proline of the second motif is not conserved among ADP/ATP carriers and is often found to be a serine. The second basic residue of the first part is replaced with a leucine, L34, in the first motif, although in the second and third, it is basic, R139 and R236. R139 participates in the interaction between M2 and M3 through E152, M238, and S241. The interaction of R236 with E264 is discussed below. The second part of the motif spans from the end of the short amphipatic helices to the N termini of the even-numbered helices. Each glycine therefore delineates a helix extremity and allows flexibility of the loop that links both helices. The acidic residues of the two first motifs, replaced with a glutamine Q64 in the first motif, participate with the interactions between M1/M2 and M2/M3, respectively. The residue of the third motif, E264, forms a salt bridge with R236, belonging to the ADP/ATP carrier signature, but also contacts K271, the basic residue of the third MCF motif (Figure 7) . These interactions clamp together the C terminus of H5 with the C terminus of h5-6 and the N terminus of H6. The basic residue at the end of the first MCF motif, R71, interacts with a CDL through a water molecule and participates with the interaction of loop M1 with M2 (through D143 and G145), and in the second motif, the residue is replaced with a glutamine, Q174. The sequence alignments of several MCF carriers highlight further conservations within the range of the second part of the MCF motif. Indeed, for ADP/ATP carriers, the short amphipatic helices and the second half of the three matrix loops are conserved in length and in sequences (alignments shown in supplementary material). Follow the Supplemental Material link from the Annual Reviews home page at http://www.annualreviews.org. On the contrary, the first half of the matrix loops, preceding the short amphipatic helices, are rather variable in length and in composition within MCF members or within the three motifs of a single carrier. 
Location of the ADP/ATP Carrier Signature
All ADP/ATP carriers that belong to the MCF are characterized by a unique signature, RRRMMM. These residues in the bovine carrier are located at the C terminus of H5. The first and the third arginines, R234 and R236, are part of the MCF motif (Figure 2a) . The structure reveals that the three arginines span the thinnest part of the protein; the side chains of R234 and R235 are accessible from the cavity open toward the IMS, and R236 points toward the matrix but is shielded from the surface by a salt bridge involving E264. R234 and R235 are part of a large hydrogen-bond network involving water molecules at the bottom of the cavity (Figure 5) . R234 is also involved in a salt bridge described above, with the MCF motif acidic residue D134, and R235 interacts with the MCF motif residue D231. Interestingly, the salt bridge between R234 and D134 was predicted from revertant studies (30) . Both arginines, R234 and R235, interact with CATR. In addition to the salt bridge with E264, R236 is implicated in a network The kinked conformation of odd-numbered helices. H1, H3, and H5, represented as ribbons, are kinked after prolines P27, P132, and P229, which are the first residues in each MCF motif. Acidic and basic residues also belonging to the MCF motif form salt bridges (dotted lines) that tie the three helices together. of hydrogen bonds including K271 and several water molecules, which link M3 to the first part of M1 (several interactions implicate residues L35, Q36, Q38, H39, I44, Q49, and Y50).
Lipids
The primitive crystal form that diffracted to 2.2-Å resolution showed the presence of two or three CDLs tightly bound to the carrier (Figure 1b,c) . Though it could not be identified as a CDL from the experimental electron density maps, the third lipid was designated as a CDL because its position was related to the two others by the pseudothreefold symmetry. The presence of three CDLs was confirmed by the second crystal form in which the three CDLs were nicely identified. CDLs are known to bind strongly to the carrier and to remain present after extraction and purification from the mitochondrial membrane (31) . CDLs are located in the inner leaflet of the membrane and partially nested in small grooves formed by matrix loops. CDL801 clamps the N terminus of h1-2 to the C terminus of h5-6 and H6. CDL800 and CDL802 interact similarly. CDL acyl chains interact with the protein through hydrophobic or aromatic residues, whereas the phosphate groups and their glycerol linkers are involved in hydrogen bonds with mainchain nitrogens or carbonyls of symmetryrelated residues located at the beginning of the short matrix helices and at the beginning of even-numbered helices. CDL801 interacts mainly with I53, I54, F270, G272, W274, and S275; CDL800 interacts with W70, G72, L74, L156, and G157; and CDL802 interacts with Y173, G175, V177, G252, T253, and V254 (7). Except for aromatic residues, most of the other residues have short side chains and interact with the lipids via main-chain atoms. Impaired activity of the carrier bearing a single mutation of either C56 or K162 could be retrieved by adding CDLs to the proteoliposomes (32, 33) . Both mutations occur in the short helices, h1-2 and h3-4, respectively, and probably destabilize the structure. CDLs could compensate for this.
Deviation to Pseudo-Threefold Symmetry
The threefold symmetry results from evolution. The existence of a structural motif repeated three times in each MCF carrier is probably related to stability but also to a common transport mechanism that allows a small molecule to cross over the membrane. Divergence from a strict threefold repeat was induced by the necessity of selective transport. Therefore, internal symmetry and also deviations from it are interesting features that have to be analyzed. The three CDLs also follow the threefold symmetry. Maximum differences are at both extremities of each motif (close to IMS loops C1 and C2) and in the first part of the matrix loops (preceding the short helices). The three repeats have a very similar skeleton, and root mean square deviations between backbone atoms of the three motifs are about 2Å [see figure 3 in (4)]. In particular, the first repeat has an additional turn in the first part of its matrix loop (one or two additional residues compared to the first parts of M3 and M2, respectively) (Figure 8) , which allows the interaction between Q43 and the side chain of D143 and main-chain atoms of V144 and Q150, as well as between K42 and D247. As a result, the loop M1 protrudes toward the center of the protein surface on the matrix side (Figure 1c) .
The backbone of H2 is bent and deviates therefore from a straight α-helix in contrast to H4 and H6. Negative charges are rather symmetrically distributed with the exception of E264, an extra negative charge, which is at Deviation from the pseudo-threefold symmetry. The superposition of repeat 1 (blue), 2 (pale green), and 3 (pale yellow) highlights the similarity of helical parts. Repeats 2 and 3 were rotated to be superimposed on repeat 1. The figure shows also a significant difference at the beginning of matrix loops (between the odd-numbered and the short helices), which is slightly longer for M1. M1 folds back toward the center of the protein, as seen in Figure 1c , and thus allows interactions with M2 and M3. Small ribbon portions of M2 and M3 are depicted in green and yellow and represent these interactions. the end of h5-6. Positively charged residues are numerous and asymmetrically distributed within the cavity, in particular at the entrance. Many charged residues are also present within the matrix loops. A global analysis of the distribution shows that all loops have an excess of positively charged residues with a ratio of positive to negative residues of 6/3, 5/3, and 7/4 for M1, M2, and M3, respectively. Aromatic residues are mainly located on the external surface of the protein, probably at the boundary between hydrophobic lipid chains and their hydrophilic head groups, as previously described for various proteins (34) . However, the third MCF repeat contains less aromatic residues, especially in the IMS region (only three compared to eight for repeat 1 and seven for repeat 2). The tyrosine ladder of the second repeat, located on H4 and composed of Y186, Y190, Y194, and also F191, has side chains oriented toward the cavity, in contrast to most aromatic residues of this IMS region in repeat 1 or 3. Aromatic residues are not uniformly distribued within the cavity but are grouped along H4. Interestingly, H4 is also the only TM helix not to be implicated in the large hydrogen-bond network described above.
The two first MCF repeats also deviate from the strict consensus sequence, and the third MCF motif is the only one that strictly obeys the motif definition. Noticeable interactions are observed between K271 and E264 as well as between E264 and R236. In addition, the third motif contains many charged amino acids, one of which, K267, interacts with a neighboring molecule in the centered crystal form both directly and also through CDL801 (7).
Conserved Residues: A Structural or Functional Role?
In order to utilize the bovine ADP/ATP structure for a general analysis of mitochondrial transport, it is of interest to compare the sequences within the ADP/ATP carriers (see supplementary material; follow the Supplemental Material link from the Annual Reviews home page at http:// www.annualreviews.org) and also within the MCF. In a first step, we relate the sequence similarities or differences within ADP/ATP carriers to structural elements observed for the bovine carrier. As for many membrane proteins, the parts protruding from the membrane are less conserved than the hydrophobic membrane-inserted parts. The most conserved region of the protein is the cavity, which has roughly twice as many strictly conserved residues (60%) (Figure 9) as the whole protein (33%) (Figure 10) . The hydrophobic region facing CDL800 is also more conserved.
Analysis of conserved residues by type shows that aromatic residues are conserved to an unusual degree (92% of the phenylalanines and 86% of the tyrosines are conserved as aromatic residues within the ADP/ATP carrier subfamily) together with charged residues (80% of aspartic acids and 76% of arginines are conserved as acid or basic residues, respectively). The cavity of ADP/ATP carriers contains an unusually high amount of positively charged residues compared to corresponding residues in other MCF carriers.
Glycine, the smallest amino acid, is known to allow large conformational flexibility for its high entropic cost of insertion in secondary structures. It is often found at the extremity of α-helices for soluble protein. Glycines are also involved in dimerization motifs GxxG for monotopic membrane proteins and favor helix-helix interactions in polytopic membrane proteins (35) . In the bovine ADP/ATP carrier structure, 70% of the glycines are conserved, and the glycine motifs present in TM helices probably play a role in intramolecular TM-TM interactions.
NUCLEOTIDE ATTRACTION AND BINDING
The specificity of nucleotide recognition and localization of their binding sites were deciphered using nucleotide derivatives and photolabeling approaches. The results obtained Conserved residues in the cavity. The representation is the same as in Figure 4 , except that residues accessible within the cavity are colored according to their conservation among ADP/ATP carriers: no similarity (gray), medium or high similarities ( yellow or orange), respectively, and identical (red ).
Figure 10
Conserved residues on external surfaces. Orientations in panels10a and 10b are the same as in 1a and 1c, respectively. Residues are colored according to conservation among ADP/ATP carriers from white to red (0% to 100% of similarity).
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can now be combined with the bovine structure, which revealed a cavity accessible to nucleotides from the IMS and highlighted the precise location of functionally important residues.
Specificity for Binding and Transport
The binding and transport properties of each MCF carrier are rather specific and were studied particularly for ADP/ATP carriers. None of the naturally occurring pyrimidine ribonucleotides 5 diphosphate and triphosphate binds to the carrier. Using synthetic analogues of purine nucleotides, it became possible to characterize the two-step sequence of the transport process, namely the recognition of a nucleotide to a specific site, followed by the vectorial process of transport. Because several adenine nucleotide analogues can bind to the carrier with a high affinity without being transported, binding requires a lower specificity than transport (36) . A central issue regarding the transport process involves the anti or syn conformation of nucleotides, which rely on the orientation of the planar purine base with respect to the ribose ring.
To be transported by the ADP/ATP carrier, a nucleotide must have a nonfixed anti conformation, with an additional amino group on C6 and an unsubstituted C2 atom. For example, 8-Br ADP and the derived 8-azido ADP, blocked in the syn conformation, bind to the carrier but are not transported. 2-azido ADP adopts the anti conformation but substitution at position 2 prevents transport. In contrast, analogues, such as formycin or tubericidin diphosphate and triphosphate and 1-N oxide-ADP or -ATP, fulfill the required structural criteria and are transported. The presence of bulky substituents at positions 2 or 3 of the ribose moiety is tolerated for binding (37) or even for transport in mitochondria (38) . Fluorescein derivatives are structurally related to adenine nucleotides and therefore are recognized by the ADP/ATP carrier, although not transported. For example, eosin Y binds to the carrier from the matrix side and inhibits the ADP/ATP transport in bovine heart inside-out submitochondrial particles (39) . These effects were interpreted on the basis of common structural features between the A/B and D rings of eosin Y, with the adenine ring and the ribose moiety of the anti form of ADP, respectively. In contrast, the absence of a negative potential at position N1 of guanine might explain why GDP is not recognized by the carrier.
The demonstration that the free forms of ADP and ATP are the actual substrates for the ADP/ATP carrier came from experiments carried out with the isolated carrier either in a detergent solution or after incorporation into the membrane of liposomes. For example, the fact that ADP-or ATP-induced conformational transitions of the isolated carrier (followed by tryptophanyl fluorescence changes) were abolished by Mg 2+ ions afforded direct evidence that Mg nucleotides are not recognized by the carrier (40) . Similarly, it was clearly demonstrated that Mg 2+ ions inhibited the ADP/ATP exchange in reconstituted proteoliposomes (41) . Finally, although AMP nucleotides are recognized by the carrier, only ADP or ATP is transported.
Biochemical Evidence for IMS-Binding Sites
Localization of two specific nucleotidebinding regions of the ADP/ATP carrier was achieved with photoaffinity radiolabeled nucleotides carrying a reactive azido group on the adenine ring. Two segments of the peptide chain of the bovine carrier, spanning residues F153 to M200 and Y250 to M281, were covalently labeled with 2-azido-ADP (42) . Mapping of the yeast carrier with 2-azido-ADP led to the labeling of a segment delimited by residues G172 and M210 (43) . A more precise assignment of the binding region was achieved with 2-azido-3 -O-naphthoyl-ADP and restricted to the S183-R191 segment, which is located in the second matrix loop between h3-4 and H4 (44). Although not directly accessible from the IMS in the CATR-ADP/ATP carrier structure, these residues are not far from the cavity, and it is possible that binding the ADP, even labeled, already induces a conformational change. An additional segment spanning residues I311-K318, corresponding to the C-terminal end of the carrier, was also labeled (44) . It was shown from the characterization of deletion mutants that this nucleotide-binding region plays a critical role for ADP/ATP transport in yeast (G. Brandolin, unpublished data). Whether the two nucleotide-binding segments belong to the same carrier monomer or to adjacent monomers is still an open question. The other peptide segments implicated in nucleotide binding also remain to be elucidated.
Structural Features
From the IMS, the patch of positive charges located at the entrance of the cavity attracts ADP 3− in spite of the opposing membrane potential and possibly provides a first nucleotidebinding site. Furthermore, positive patches in the middle and at the bottom of the cavity attract nucleotides to the bottom. The cavity narrows at a bottleneck located at 20Å from the entrance. The four residues surrounding the bottleneck are conserved only within the ADP/ATP carrier subfamily (except for the carrier involved in Grave's disease for which the transported molecule has not yet been clearly identified). These are three basic residues, K22, R79, and R279 (the two arginines related by the internal pseudosymmetry), and Y186, which belongs to the tyrosine ladder. Mutations of the residues, corresponding to K22 and R79 in yeast, severely impair the transport properties ( Table 1) . Coming from the IMS, a nucleotide could glide with its adenine ring along H4 using the tyrosine ladder, whereas the phosphates would follow the basic patches. At the level of the constriction, the four residues could restrict the entrance to the bottom of the cavity to adenine nucleotides. The cavity is limited to 8Å. It is therefore interesting to note that the residues of the putative selectivity filter, K22, R79, Y186, and R279, correspond to R190, K241, Y338, and K434 in the human Mg-ATP/Pi carrier, which imports Mg-ATP and exports Pi. Although the lysines and arginines are switched, the same types of residues are found at the same locations. In addition, the Mg-ATP/Pi carrier also exhibits two out of the three tyrosines forming the ladder, and the positive patches are conserved, except for the second one (R187 and K91 do not correspond to positive residues). Regarding the cavity, the Mg-ATP/Pi carrier and the carrier implicated in Grave's disease are the most similar to the ADP/ATP carrier in terms of charged and aromatic residues.
The phosphate carrier is another MCF member in which several residues, including H32, T79, Y83, K90, Y94, and K98, were expected to be important in the transport pathway (45) . Interestingly, H32 and T79, residues that are unique to phosphate carriers, correspond to K22 and N76, respectively, of the bovine ADP/ATP carrier. K22 is described herein as belonging to a putative selectivity filter, and N76 is located close to it.
Binding ATP from the Matrix
From the structure obtained in the presence of CATR, it is difficult to deduce ATP-binding sites. However, it highlights a salt bridge between R236 and E264 (Figure 3) . R236 could be involved in ATP binding, thus modifying the salt bridge and inducing a conformational change. Binding of eosin Y, a non-thiol-reactive molecule, was shown to be displaced by ADP or ATP, and therefore eosin Y was supposed to bind in close vicinity to the nucleotide site. In addition, binding of eosin Y also prevented the thiol-reactive eosin-5-maleimide molecule to bind on C159 (39) . The authors therefore suggested that ATP binds in the vicinity of C159. However, in the absence of further structural data, it is difficult to discuss the ATP-binding site from the matrix.
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TRANSPORT MECHANISM
The binding of nucleotides to the carrier has to induce conformational changes that trigger a one-to-one ADP/ATP exchange. The structure in the presence of CATR and biochemical data offer a basis for the discussion on transport mechanism.
Conformational Changes
The very high selectivity of the ADP/ATP carrier for adenine nucleotides and the recognition of fully charged species instead of partially neutralized Mg 2+ -nucleotide complexes considerably enhance the binding energy of nucleotide-carrier interaction, which in turn is used to drive the ADP and ATP translocation. Energy supply has to sustain the conformational rearrangements of the carrier required to transport large and charged nucleotides. The general concept of an induced transition fit mechanism that would provide energy for transport through the formation of a transient carrier-substrate complex has recently been discussed (46) . Indeed, normal mode calculations based on the structure of the bovine ADP/ATP carrier show that lowenergy movements are not sufficient to induce structural conformations that would allow the transport of the nucleotides (P. Amara, personal communication). However, conformation fluctuations in the unloaded carrier could be necessary to expose transiently the conformations to which ADP and ATP bind. The additional energy needed for the transport process could come from the relaxation of both ADP 3− and ATP 4− in their binding sites. The conformation changes undergone by the carrier are a central issue with regard to the molecular mechanism of the ADP/ATP transport. This point was addressed by studying the modification of the carrier topography in the presence of CATR and BA. Conformers of the carrier were differentiated on the basis of their enzymatic, immunochemical, and chemical reactivities (for a review, see Reference 47) . Experiments with the bovine heart ADP/ATP carrier have shown that the CATR-carrier complex is more iodinated than the BA-carrier complex or the denatured carrier (48) . The N-terminal region of the membrane-bound bovine carrier, which is exposed to the IMS in intact mitochondria, is particularly sensitive to conformational changes; its reactivity to antibodies is much higher in the presence of CATR than of BA (49) . In addition, systematic singlecysteine mutants on the yeast carrier followed by thiol accessibility exploration showed that the accessibility of residues 98 to 106 (equivalent to 81-89 in the bovine carrier) is drastically modified in the presence of BA compared to CATR (50) . The modifications were interpreted by the authors as a 180
• twist of H2. Residues 81 to 89 of the bovine carrier are located in the vicinity of the N-terminal end up to residue 12; therefore structural modifications of H2 could be correlated to that of the N terminus. The conformational changes undergone by the ADP/ATP carrier also affect peptide segments located on the matrix side. Thus, the extent of C56 alkylation by N-ethylmaleimide in the presence of ADP or ATP is enhanced by BA and counteracted by CATR (51) . In addition, the K42-Q43, K146-G147, and K244-G245 bonds, which are not accessible in the native membrane of inverted mitochondrial particles, become unmasked and accessible for cleavage by specific proteases in the presence of BA (52) . Additional conformation-dependent thiol-labeling and cross-linking experiments carried out on the bovine carrier with maleimide reagents were interpreted in terms of the participation of the matrix-exposed loops to the transport process. In particular, a critical gating role was proposed for loop M1, which is positively charged and could attract a nucleotide and convey it to a binding domain located on loop M2 (53) . We have recently demonstrated by proteolytic and chemical labeling approaches that loop M2 of the yeast ADP/ATP carrier undergoes conformation-dependent swinging, probably related to the transport process (53a).
The bovine ADP/ATP carrier structure determined in the presence of CATR shows several interactions between matrix loops. Because of its difference in length and asymmetrical position, M1 plays a central role (Figures 1c and 8) . The first part of M1 (between H1 and h1-2) interacts with the Cterminal ends of H3 and H5 as well as with the first part of M3 (notably through a salt bridge between K42 and D247). The interactions between M1 and M2 involve the second part of M1 (between h1-2 and H2) and the first part of M2 (between H3 and h3-4). Similar interactions, obtained by circular permutation, are observed between M2 and M3. The interaction between M1 and M3 implicates the C-terminal ends of H1 and h5-6. Many polar or electrostatic interactions among the matrix loops are observed. It is therefore difficult to conceive that one single loop could move during transport without affecting the conformation of the other loops. Conversely, if dimerization of the carrier is necessary for its function, the dimerization interface breaks the threefold symmetry. Combining both aspects, it is conceivable that even if all three matrix loops move during transport, the amplitude of these movements might be different for each of them.
The structure also suggests that modifications of the kink angles in odd-numbered helices would induce large conformational changes, reorienting the short amphipatic loops (helped by the presence of conserved glycines of the MCF motif) and changing the accessibility of the cysteines as demonstrated by cross-linking experiments. Such modifications may be general for all MCF members.
What Triggers the Changes? Kinetic Aspects
The kinetic properties of the ADP/ATP carrier have been studied in detail in isolated mitochondria and after functional reconstitution in proteoliposomes. Most of the mitochondrial carriers were shown to catalyze strict solute exchange reactions (54, 55) ; this is also the case of the ADP/ATP carrier. In isolated mitochondria, stoichiometry of the exchange was assessed in experiments in which nonmetabolized transportable analogues were used instead of ADP. This avoided the difficult measurements linked to dephosphorylation and transphosphorylation of the external nucleotide once it has been transported into the matrix space. Using AOPCP, a methylene analogue of ADP, the stoichiometry of the exchange with intramitochondrial nucleotides is 1 (for a review, see Reference 56) . A 1-to-1 stoichiometry of exchange was also determined for the ADP/ATP transport system reconstituted in proteoliposomes from the isolated bovine heart carrier (41) . In contrast, a uniport function of the ADP/ATP carrier was deduced from investigation of the reconstituted ADP/ATP transport in black lipid membranes (57) . In this approach, measurements of electrical currents associated with the functioning of the carrier upon photolysis of caged ADP/ATP were interpreted as reflecting net transport of nucleotides.
In isolated rat heart and rat liver mitochondria, the ADP/ATP transport was demonstrated to proceed according to a sequential mechanism in which both the external substrate and the internal substrate bind to the carrier before the translocation occurs (58, 59) . This intermolecular mechanism implies the existence of positive interactions between distinct binding sites exposed to the outer and inner face of the membrane-embedded carrier. Consistent with these findings, the occurrence of distinct specific nucleotide-binding sites on the ADP/ATP carrier was deduced from the binding of ADP and ATP derivatives to the carrier either in the membrane-bound state or when isolated in detergent solution (60) (61) (62) . For example, in the mitochondrial membrane, two specific nucleotide-binding sites are located on the same face of the membrane, either the IMS face of intact mitochondria or the matrix face of inside-out particles. Negative interactions between adjacent sites were evidenced for the binding of transported nucleotides but not for that of nontransportable nucleotides, such as naphthoyl-ADP, thus illustrating that the binding step triggers conformational changes responsible for negative cooperativity, which is set up prior to the transport process.
The structure shows that the negatively charged ADP attracted to the bottom of the cavity could interact with the basic residues of the MCF motifs and thus interfere with the salt bridges that strengthen the closed form. The binding of ADP itself could be one element that triggers the conformational changes, which result in nucleotide transport. An additional element could be the binding of ATP from the matrix. Combining the hypothesis of a selectivity filter with the conformational changes triggered by substrate binding would explain the selectivity of each MCF member, despite a common mechanism based on a similar structure induced by the MCF motifs for all the carriers of this family. The slow turnover of ADP/ATP carriers (about 1000 min −1 ) (63) is compatible with the large structural changes hypothetized from the kinked helices and is necessary for the transport of nucleotides but not for ion transporters (64) .
Is the Functional Unit a Dimer?
Experimental evidence for oligomerization. Ever since the discovery of the ADP/ ATP carrier in the 1970s, several biochemical and biophysical experiments indicated that MCF members are dimeric. Mainly three types of experiments were performed. The first type led to a stoichiometry, the second gave a particle mass, and the third was based on distances between given residues of neighboring molecules. Klingenberg and coworkers first proposed the functional unit to be a dimer (65, 66) on the basis of inhibitor stoichiometry studies. Measuring CATR amounts by 35 S radioactivity and protein concentration with modified Biuret or Lowry protocols, a 0.55 molar ratio of CATR-to-protein was determined. Analytical ultracentrifugation was carried out with the ADP/ATP carrier (67) and the uncoupling protein (UCP) (68) . Both proteins were solubilized in Triton X-100. The total CATR-ADP/ATP carrier micelle mass was ∼180 kDa and dropped to 65 kDa, which corresponds to a dimer, after subtracting the contributions of detergent and lipids. The mass of UCP micelles was also compatible with a dimeric organization. However, similar experiments on the yeast ADP/ATP carrier solubilized in dodecyl maltoside (M. LeMaire, personal communication) or the bovine carrier (C. Ebel, personal communication) evidenced a monomer. Small-angle neutron scattering of the bovine ADP/ATP carrier solubilized in LAPAO led to a particle mass compatible with a dimer in the presence of both inhibitors CATR or BA (69) . However, the bovine ADP/ATP carrier is usually solubilized with a large amount of detergent and lipids, and it is difficult to correct for these contributions to the scattering.
Native electrophoresis has been used for several mitochondrial carriers [ADP/ATP (70), 2-oxoglutarate (71), citrate (72), tricarboxylate (73)], and this led the authors to conclude that a dimeric organization exists. From in vivo and in vitro assembly of ADP/ATP and 2-oxoglutarate carriers, it was proposed that newly imported carriers assemble rapidly with the few preexisting monomers in the inner membrane, with the vast majority of the carrier pool being dimeric. Using double-tagged proteins, the phosphate carrier is the only one for which functional observations were related to the existence of a dimer (74) .
Covalent dimers of the yeast ADP/ATP carrier, wherein the C terminus of the first monomer is fused to the N terminus of the second one, were found to be functional (75) (76) (77) . The transport activity or inhibitor binding of chimeric proteins is similar to the native ones. From these experiments, the authors suggest a proximity of H1 from one monomer with H6 from the second one. However, the segment bridging H6 from one monomer to H1 from the other could, if unstructured, span over more than 100Å. A disulfide bridge between C28 of two yeast phosphate carriers inhibits transport (78) , and thus, it was proposed that C28 is at the interface between monomers. An interface involving H3 and H4 also was proposed after homology modeling of the yeast citrate carrier structure (79) .
The oligomeric state and the conformational changes of the ADP/ATP carrier were extensively investigated for years using thiol labeling or cross-linking with naturally occurring cysteines or single-cysteine mutants. Almost all the loops of the protein were explored in the presence of CATR or BA. Such experiments on the first IMS loop showed that the conformation of the first part of the loop is different with both inhibitors (80) . The authors suggest that C1 could act as a swinging gate during ADP uptake from the IMS. The gate would be related to a partial unwinding of the C terminus of H2. These suggestions are in line with the proposed dimer in which C2 loops from both monomers interact on the IMS side, thus allowing flexibility for C1 loops. In addition, the secondary structure of H2 is bent toward its C-terminal end, possibly indicating a certain flexibility of the helix. On the basis of cysteine interactions (direct or induced through linkers), it was shown that C56 from both monomers located in loop M1 can be cross-linked in the presence of BA (53, 81) .
Altogether, the experimental results do not converge clearly toward a single dimeric organization among all MCF carriers or even within a specific type of carriers. The discrepancies among the ADP/ATP carriers could result from a rather loose oligomeric organization in which protein-protein interactions could occur for the transport process but in which carriers are otherwise only in close vicinity. The oligomeric state could also depend on experimental conditions, such as native membrane versus detergent micelles or protein and detergent concentration. It could also be that other MCF carriers have evolved differently and that their dimeric interfaces are varied. Another possibility is the existence of higher oligomeric interactions.
Consequences for the mechanism. On the basis of inhibitor and substrate-binding studies, a single-binding-center gated pore (SBGP) mechanism has been advocated by Klingenberg (82) . According to this model, a single binding site for substrates and inhibitors, located within the core of the protein, is assumed to be alternately accessible to each side of the membrane during the different steps of transport. The entrance and the exit of the substrate would be mediated by two gates, each gate facing one side of the membrane. A key feature of this model is that in order to prevent leakage, binding of the substrate controls the closing of the entrance gate and the opening of the exit gate on the opposite side of the membrane. Because of the possible dimeric organization of the carrier, it has been proposed that the SBGP mechanism operates with a single translocation pathway formed at the interface of two monomers (83) or formed by the merging of the 12 TM helices (84) . Both arrangements are most unlikely because the bovine ADP/ATP carrier structure shows that a monomer presents a deep cavity, probably belonging to a translocation pathway. Therefore the transport function of a dimeric carrier would involve two transport pathways, which is consistent with a sequential type of mechanism because the carrier would be loaded simultaneously with an internal and an external nucleotide.
Gating of the channels is a compulsory function that can be generalized to most transport systems, including channels with either one or two gates opened simultaneously. It is conceivable that the switch of a carrier mode to a channel mode results from concerted opening of the gates, induced, for example, by site-directed mutagenesis or by chemical modifications of the carriers. Conversion of carrier function to channel-like function has been illustrated for a number of mitochondrial carriers, including the ADP/ATP carrier, as reviewed in Reference 85.
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Figure 11
Protein-protein interaction mediated by CDLs. The two monomers seen in the crystal packing interact directly next to the matrix side and to the IMS. The interaction also involves cardiolipins (gray). Van der Waals surfaces of proteins and lipids are shown superposed on the ribbons for the protein and on the balls and sticks for the lipids.
HYPOTHESES AND CONCLUSIONS
A Proposed Mechanism Involving CDLs
A second crystal form of the bovine ADP/ATP carrier revealed possible monomer-monomer interactions favored by CDLs (Figure 11 ) (7) . The importance of CDLs was already known for ADP/ATP carrier activity, and three CDLs were shown to be tightly associated to one monomer (31) . Although CDLs are not essential for the growth of yeast cells on fermentable and nonfermentable carbon sources (86) , the activity of ADP/ATP transport in the absence of CDL has been shown to be lowered to 20% of the level seen in mitochondria of wild-type cells (87) . Retrieving the activity of different mutants in proteoliposomes in the presence of CDLs indicated that these lipids are important for the function and the stability of the carrier (32) . On the matrix side, numerous interactions between the N-terminal end of h1-2 of one carrier with the C-terminal end of h5-6 from the second carrier involve K267 and K51 and also the phosphates of CDL801. On the IMS, the interaction is looser and implicates loops C2 from both monomers. Within the membrane, hydrophobic contacts are made through the lipid alkyl chains. Prolines of the MCF motif, P27, P132, and P229, have aromatic environments similar to W70, Y173, and F270, each of which stacks on one of the three CDLs. We postulate that the cross talk between monomers during the transport process could implicate the CDLs and that aromatic residues relay the signal from the proline kink modification to the lipid and act as a driving belt. Indeed, P229 (located in the third MCF repeat) interacts with CDL801 (Figure 7) close to the putative dimer interface (Figure 11) . It is also interesting to note that residues Y228 and F230, which are close to P229, prolongate the tyrosine ladder present in the cavity. In this model, H2 is at the opposite side of the dimer interface. This location is consistent with the hypothesis that this helix twists during the transport. In addition, several residues belonging to the basic patches of the cavity belong to H2. From the entrance, the first patch comprises R104, belonging to C1, the second K91 and K95, and the third R79, known to be crucial for the binding and the transport of nucleotides. Therefore, binding of ADP to the cavity from the IMS could induce this twist (50) .
Open Questions
Elucidating the transport mechanism of mitochondrial ADP/ATP carriers necessitates a combination of various approaches. Highresolution structural approaches such as X-ray crystallography are very powerful and highlight the quasi-atomic structure of the carrier locked into a precise conformational state. This structure provides a good starting point
